Inhibition of TC-1 Cytokine Production, Effector Cytotoxic T Lymphocyte Development and Alloantibody Production by 2,3,7,8-Tetrachlorodibenzo-p-Dioxin

Journal of Immunology

Volumn 157, Issue 6, 1996, Pages 2310-2319

  Kerkvliet, N I ^a   Baecher Steppan, L ^a   Shepherd, D M ^a   Oughton, J A ^a   Vorderstrasse, B A ^a   DeKrey, G K ^a,b  

^a OREGON STATE UNIVERSITY   (United States)

^b University of Colorado   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; ALLOANTIBODY; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN CLASS; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2; LYMPHOCYTE ANTIBODY; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; BIOSYNTHESIS; C57BL MOUSE; CANCER TRANSPLANTATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CULTURE; CLASSIFICATION; CYTOLOGY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY TEST; DBA MOUSE; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; GENETICS; IMMUNOLOGY; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; MALE; MOUSE; SARCOMA; SPLEEN;

ANIMALS; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; ANTILYMPHOCYTE SERUM; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; CYTOTOXICITY TESTS, IMMUNOLOGIC; FEMALE; IMMUNOGLOBULIN ISOTYPES; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE AGENTS; INTERFERON TYPE II; INTERLEUKIN-2; ISOANTIBODIES; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; MALE; MAST-CELL SARCOMA; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; NEOPLASM TRANSPLANTATION; RNA, MESSENGER; SPLEEN; T-LYMPHOCYTES, CYTOTOXIC; TETRACHLORODIBENZODIOXIN; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030587178     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Nebert, D. W., A. Puga, and V. Vasiliou. 1993. Role of the Ah receptor and the dioxin-inducible [Ah] gene battery in toxicity, cancer, and signal transduction. Ann. NY Acad. Sci. 685:624.
2. Fisher, J. M., K. W. Jones, and J. P. Whitlock, Jr. 1989. Activation of transcription as a general mechanism of 2,3,7,8-tetrachlorodibenzo-p-dioxin action. Mol. Carcinog. 1:216.
3. Hankinson, O. 1995. The aryl hydrocarbon receptor complex. Annu. Rev. Pharmacol. Toxicol. 35:307.
4. Stohs, S. J., B. D. Abbott, F. H. Lin, and L. S. Birnbaum. 1990. Induction of ethoxyresorufin-o-deethylase and inhibition of glucocorticoid receptor binding in skin and liver of haired and hairless HRS/J mice by topically applied 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicology 65:123.
5. Sutter, T. R., K. Guzman, K. M. Dold, and W. F. Greenlee. 1991. Targets for dioxin: genes for plasminogen activator inhibitor-2 and interleukin-1β. Science 254:415.
6. Gaido, K. W., and S. C. Maness. 1994. Regulation of gene expression and acceleration of differentiation in human keratinocytes by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol. Appl. Pharmacol. 127:199.
7. Madhukar, B. V., D. W. Brewster, and F. Matsumura. 1984. Effects of in vivo-administered 2,3,7,8-tetrachlorodibenzo-p-dioxin on receptor binding of epidermal growth factor in the hepatic plasma membrane of rat, guinea pig, mouse and hamster. Proc. Natl. Acad. Sci. USA 81:7407.
8. Lucier, G. W., A. Tritscher, T. Goldworthy, J. Foley, G. Clark, J. Goldstein, and R. Maronpot. 1991. Ovarian hormones enhance 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated increases in cell proliferation and preneoplastic foci in a two-stage model for rat hepatocarcinogenesis. Cancer Res. 51:1391.
9. Abbott, B. D., M. W. Harris, and L. S. Birnbaum. 1992. Comparisons of the effects of TCDD and hydrocortisone on growth factor expression provide insight into the synergistic interactions occurring in embryonic palates. Teratology 45: 35.
10. Vos, J. G., and M. I. Luster. 1989. Immune alterations. In Halogenated Biphenyls, Terphenyls, Naphthalenes, Dibenzodioxins and Related Products. R. D. Kimbrough and S. Jensen, eds. Elsevier Science Publishers (Biomedical Division), New York, p. 295.
11. Kerkvliet, N. I., and G. R. Burleson. 1994. Immunotoxicity of TCDD and related halogenated aromatic hydrocarbons. In Immunotoxicology and Immunopharmacology, 2nd Ed. J. H. Dean, M. I. Luster, A. E. Munson, and I. Kimber, eds. Raven Press, New York, p. 97.
12. Mantovani, A., A. Vecchi, W. Luini, M. Sironi, G. P. Candiani, F. Spreafico, and S. Garattini. 1980. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on macrophage and natural killer cell mediated cytotoxicily in mice. Biomedicine 32:200.
13. Kerkvliet, N. I., and J. A. Oughton. 1993. Acute inflammatory response to SRBC in mice treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): phenotypic and functional analysis of peritoneal exudate cells. Toxicol. Appl. Pharmacol. 119:248.
14. Moos, A. B., L. Baecher-Steppan, and N. I. Kerkvliet. 1994. Acute inflammatory response to sheep red blood cells in mice treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin: the role of proinflammatory cytokines, IL-1 and TNF. Toxicol. Appl. Pharmacol. 127: 331.
15. Davis, D., and S. Safe. 1991. Halogenated aryl hydrocarbon-induced suppression of the in vitro plaque-forming cell response to sheep red blood cells is not dependent on the Ah receptor. Immunopharmacology 21:183.
16. Luster, M. I., D. R. Germolec, G. Clark, G. Wiegand, and G. J. Rosenthal. 1988. Selective effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin and corticosteroid on in vitro lymphocyte maturation. J. Immunol. 140:928.
17. Clark, G. C., J. A. Blank, D. R. Germolec, and M. I. Luster. 1991. 2,3,7,8-Tetrachlorodibenzo-p-dioxin stimulation of tyrosine phosphorylation in B lymphocytes: potential role in immunosuppression. Mol. Pharmacol. 39:495.
18. Lang, D. S., S. Becker, G. C. Clark, R. B. Devlin, and H. S. Koren. 1994. Lack of direct immunosuppressive effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on human peripheral blood lymphocyte subsets in vitro. Arch. Toxicol. 68:296.
19. Morris, D. L., S. D. Jordan, and M. P. Holsapple. 1991. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on humoral immunity. I. Similarities to Staphylococcus aureus Cowan Strain 1 (SAC) in the in vitro T-dependent antibody response. Immunopharmacology 21:159.
20. Lundberg, K., L. Dencker, and K.-O. Gronvik. 1990. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) treatment in vivo or thymocyte functions in mice after activation in vitro. Int. J. Immunopharmacol. 12:459.
21. DeKrey, G. K., and N. I. Kerkvliet. 1995. Suppression of cytotoxic T lymphocyte activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin occurs in vivo, but not in vitro, and is independent of corticosterone elevation. Toxicology 97:105.
22. Kerkvliet, N. I., L. Baecher-Steppan, B. B. Smith, J. A. Youngberg, M. C. Henderson, and D. R. Buhler. 1990. Role of the Ah locus in suppression of cytotoxic T lymphocyte activity by halogenated aromatic hydrocarbons (PCBs and TCDD): structure-activity relationships and effects in C57B1/6 mice congenic at the Ah locus. Fundam. Appl. Toxicol. 14:532.
23. Clark, D. A., J. Gauldie, M. R. Szewczuk, and G. Sweeney. 1981. Enhanced suppressor cell activity as a mechanism of immunosuppression by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Proc. Exp. Biol. Med. 168:290.
24. Kerkvliet, N. I., and L. Baecher-Steppan. 1988. Suppression of allograft immunity by 3,4,5,3′,4′,5′-hexachlorobiphenyl. II. Effects of exposure on mixed lymphocyte reactivity and induction of suppressor cell activity in vitro. Immunopharmacology 16:13.
25. Clark, D. A., G. Sweeney, S. Safe, E. Hancock, D. G. Kilburn, and J. Gauldie. 1983. Cellular and genetic basis for suppression of cytotoxic T cell generation by haloaromatic hydrocarbons. Immunopharmacology 6:143.
26. MEL-14 (LECAM-1), Pgp-1, LFA-1, and VLA-4α during the differentiation of cytotoxic T lymphocytes induced by allografts. J. Immunol. 148:2348.
27. Bishop, D. K., W. Li, S. Y. Chan, R. D. Ensley, J. Shelby, and E. J. Eichwald. 1994. Helper T lymphocyte unresponsiveness to cardiac allografts following transient depletion of CD4-positive cells. Implication for cellular and humoral responses. Transplantation 58:576.
28. Hogan, M., and S. Vogel. 1993. Measurement of tumor necrosis factor α and β. In Current Protocols in Immunology. J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober, eds. John Wiley and Sons, New York, p. 6.10.1.
29. Noelle, R. J., D. M. Shepherd, and H. P. Fell. 1992. Cognate interaction between T helper cells and B cells. VII. Role of contact and lymphokines in the expression of germ-line and mature γ1 transcripts. J. Immunol. 149:1164.
30. Wysocki, L. J., and V. L. Sato. 1978. "Panning" for lymphocytes: a method for cell selection. Proc. Natl. Acad. Sci. USA 75:2844.
31. Chace, J. H., J. S. Chowdry, and E. H. Field. 1994. Effect of anti-CD4 on CD4 subsets. I. Anti-CD4 preferentially deletes resting, naive CD4 cells and spares activated CD4 cells. J. Immunol. 152:405.
32. Renauld, J.-C., A. Vink, and J. Van Snick. 1989. Accessory signals in murine cytolytic T cell responses. Dual requirement for IL-1 and IL-6. J. Immunol. 143: 1894.
33. Farrar, W. L., H. M. Johnson, and J. J. Farrar. 1981. Regulation of the production of immune interferon and cytotoxic T lymphocytes by interleukin 2. J. Immunol. 126:1120.
34. Andrus, L., A. Granelli Piperno, and E. Reich. 1984. Cytotoxic T cells both produce and respond to interleukin 2. J. Exp. Med. 159:647.
35. Maraskovsky, E., W.-E. Chen, and K. Shortman. 1989. IL-2 and IFN-γ are two necessary lymphokines in the development of cytolytic T cells. J. Immunol. 143: 1210.
36. Quentmeier, H., J. Klaucke, P. F. Muhlradt, and H. G. Drexler. 1992. Role of IL-6, IL-2, and IL-4 in the in vitro induction of cytotoxic T cells. J. Immunol. 149:3316.
37. Widmer, M. B., and K. H. Grabstein. 1987. Regulation of cytolytic T-lymphocyte generation by B-cell costimuatory factor. Nature 326:795.
38. Gajewski, T. F., J.-C. Renauld, A. Van Pel, and T. Boon. 1995. Costimulation with B7-1, IL-6, and IL-12 is sufficient for primary generation of murine antitumor cytolytic T lymphocytes. J. Immunol. 154:5637.
39. Simon, M. M., U. Hochgeschwender, U. Brugger, and S. Landolfo. 1986. Monoclonal antibodies to interferon-gamma inhibit interleukin 2-dependent induction of growth and maturation in lectin/antigen-reactive cytolytic T lymphocyte precursors. J. Immunol. 136:1629.
40. Takai, Y., S. H. Herrmann, J. L. Greenstein, G. L. Spitalny, and S. J. Burakoff. 1986. Requirement for three distinct lymphokines for the induction of cytotoxic T lymphocytes from thymocytes. J. Immunol. 137:3494.
41. Ranges, G. E., I. S. Figari, T. Espevik, and M. A. Palladino. 1987. Inhibition of cytotoxic T cell development by transforming growth factor β and reversal by recombinant tumor necrosis factor α. J. Exp. Med. 166:991.
42. Robinet, E., D. Branellec, M. Termijtelen, J. Y. Blay, F. Gay, and S. Chouaib. 1990. Evidence for tumor necrosis factor-α involvement in the optimal induction of class I allospecific cytotoxic T cells. J. Immunol. 144:4555.
43. Siebenkotten, G., and A. Radbruch. 1995. Towards a molecular understanding of immunoglobulin class switching. Immunologist 3:141.
44. + cytolytic T-lymphocyte clones. J. Exp. Med. 156:1280.
45. Loveland, B. E., and I. F. C. McKenzie. 1982. Cells mediating graft rejection in the mouse. II. The Lyt phenotypes of cells producing tumor allograft rejection. Transplantation 33:174.
46. Birnbaum, L. S. 1986. Distribution and excretion of 2,3,7,8-tetrachlorodibenzo-p-dioxin in congenic strains of mice which differ at the Ah locus. Drug Metab. Dispos. 14:34.
47. + T cells secreting Th1 or Th2 cytokines. Immunity 2:271.
48. Landolfo, S., F. Cofano, M. Giovarelli, M. Prat, G. Cavallo, and G. Forni. 1985. Inhibition of interferon gamma may suppress allograft reactivity by T lymphocytes in vitro and in vivo. Science 229:176.
49. Dallman, M. J., K. J. Wood, K. Hamano, A. R. Bushell, P. J. Morris, M. J. A. Wood, and H. M. Charlton. 1993. Cytokines and peripheral tolerance to alloantigen. Immunol. Rev. 133:5.
50. Bugeon, L., M.-C. Cuturi, M.-M. Hallet, J. Paineau, D. Chabannes, and J.-P. Soulillou. 1992. Peripheral tolerance of an allograft in adult rats: characterization by low interleukin-2 and interferon-γ mRNA levels and by strong accumulation of major histocompatibility complex transcripts in the graft. Transplantation 54: 219.
51. + T cells results in Th2 cytokine production and alternate mechanism of allograft rejection. Transplantation 59:1155.
52. Andris, F., O. Leo, M. Van Mechelen, J. Urgain, and M. Slaqui, M. 1989. CD4-Ia interactions can occur in the absence of T-cell receptor/Ag-Ia recognition. Immunology 68:1.
53. - H-2-different tumor cells in the Winn assay. J. Immunol. 140:2899.
54. Schwartz, R. H. 1992. Costimulation of T lymphocytes: the role of CD28, CTLA-4 and B7/BB1 in interleukin-2 production and immunotherapy. Cell 71: 1065.
55. Mondino, A., and M. K. Jenkins. 1994. Surface proteins involved in T cell costimulation. J. Leukocyte Biol. 55:805.
56. Lawrence, B. P., M. Leid, and N. I. Kerkvliet. 1996. Distribution and behavior of the Ah receptor in murine T lymphocytes. Toxicol. Appl. Pharmacol. 138:275.
57. Prell, R. A., J. A. Oughton, and N. I. Kerkvliet. 1995. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on anti-CD3 induced changes in T cell subsets and cytokine production. Int. J. Immunopharmacol. 17:951.
58. Szebeni, J., M.-G. Wang, D. A. Pearson, G. L. Szot, and M. Sykes. 1994. IL-2 inhibits early increases in serum gamma interferon levels associated with graft-versus-host-disease. Transplantation 58:1385.
59. + T cell clones cycles in response to IL-2. J. Immunol. 151:4055.